JP2023531918A5 - - Google Patents
Info
- Publication number
- JP2023531918A5 JP2023531918A5 JP2022578615A JP2022578615A JP2023531918A5 JP 2023531918 A5 JP2023531918 A5 JP 2023531918A5 JP 2022578615 A JP2022578615 A JP 2022578615A JP 2022578615 A JP2022578615 A JP 2022578615A JP 2023531918 A5 JP2023531918 A5 JP 2023531918A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- acid
- pharmaceutical formulation
- formulation according
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063043075P | 2020-06-23 | 2020-06-23 | |
| US63/043,075 | 2020-06-23 | ||
| PCT/US2021/038564 WO2021262779A1 (en) | 2020-06-23 | 2021-06-23 | Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531918A JP2023531918A (ja) | 2023-07-26 |
| JP2023531918A5 true JP2023531918A5 (https=) | 2024-06-28 |
Family
ID=79281832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022578615A Withdrawn JP2023531918A (ja) | 2020-06-23 | 2021-06-23 | （１ｓ）－１－フェニル－２－ピリジン－２－イルエタンアミンの局所製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12564579B2 (https=) |
| EP (1) | EP4168116A4 (https=) |
| JP (1) | JP2023531918A (https=) |
| KR (1) | KR20230026449A (https=) |
| CN (1) | CN115836052A (https=) |
| AU (1) | AU2021297823A1 (https=) |
| BR (1) | BR112022025900A2 (https=) |
| CA (1) | CA3187140A1 (https=) |
| IL (1) | IL299308A (https=) |
| MX (1) | MX2022016183A (https=) |
| PH (1) | PH12022553502A1 (https=) |
| WO (1) | WO2021262779A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024220093A2 (en) * | 2023-04-20 | 2024-10-24 | LifeActive, Inc. | Transdermal delivery formulations and methods for the manufacture thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0594729A1 (en) * | 1991-07-17 | 1994-05-04 | Pfizer Inc. | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| DE69317411T2 (de) | 1992-04-03 | 1998-07-30 | Ab Astra, Soedertaelje | Enantiomere 1-phenyl-2-(2-pyridinyl)ethylamin für die behandlung neurodegenerativer störungen |
| US20040082543A1 (en) * | 2002-10-29 | 2004-04-29 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain |
| RS58991B1 (sr) | 2013-11-05 | 2019-08-30 | Astrazeneca Ab | Prolekovi nmda antagonista |
| US11358935B2 (en) | 2016-11-28 | 2022-06-14 | Biohaven Pharmaceutical Holding Company Ltd. | Prodrugs of lanicemine and their method of use |
| US12090145B2 (en) * | 2018-08-20 | 2024-09-17 | Yale University | Combination therapy for treating or preventing depression or other mood diseases |
-
2021
- 2021-06-23 IL IL299308A patent/IL299308A/en unknown
- 2021-06-23 AU AU2021297823A patent/AU2021297823A1/en not_active Abandoned
- 2021-06-23 JP JP2022578615A patent/JP2023531918A/ja not_active Withdrawn
- 2021-06-23 MX MX2022016183A patent/MX2022016183A/es unknown
- 2021-06-23 PH PH1/2022/553502A patent/PH12022553502A1/en unknown
- 2021-06-23 BR BR112022025900A patent/BR112022025900A2/pt not_active Application Discontinuation
- 2021-06-23 EP EP21829394.2A patent/EP4168116A4/en active Pending
- 2021-06-23 US US17/923,585 patent/US12564579B2/en active Active
- 2021-06-23 CN CN202180044182.0A patent/CN115836052A/zh active Pending
- 2021-06-23 KR KR1020237001959A patent/KR20230026449A/ko not_active Withdrawn
- 2021-06-23 CA CA3187140A patent/CA3187140A1/en active Pending
- 2021-06-23 WO PCT/US2021/038564 patent/WO2021262779A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890000493B1 (ko) | 국소외용 약학적 조성물의 제조방법 | |
| JP2022174168A (ja) | ω３脂肪酸の自己乳化組成物 | |
| JP6794420B2 (ja) | 外用医薬組成物 | |
| CN105120839B (zh) | 可注射长效局麻药半固体制剂及其组成成分 | |
| JP2016532643A5 (https=) | ||
| RU2014102958A (ru) | Сложные эфиры для лечения офтальмологических воспалительных заболеваний | |
| EP2055298A1 (en) | Topical composition | |
| RU2015104019A (ru) | Композиция для местного применения, содержащая пленкообразующий полимер, для доставки активного ингредиента на кожу | |
| JP2022529720A (ja) | レナリドミドまたは他の免疫調節剤の持続投与 | |
| JP6903410B2 (ja) | 水中油型乳化組成物 | |
| KR20110027838A (ko) | 광선 각화증을 치료하기 위한 국소 조성물 | |
| JP2016532645A5 (https=) | ||
| JP2025515474A5 (https=) | ||
| JP2016532644A5 (https=) | ||
| JP2023531918A5 (https=) | ||
| TWI716394B (zh) | 外用醫藥組合物 | |
| JP2018515463A5 (https=) | ||
| JP2022504250A (ja) | ケトンの経皮投与のための製剤および方法 | |
| US20170119841A1 (en) | Amino acid salts of unsaturated fatty acids | |
| EP4126057B1 (en) | Composition having improved voluntary acceptance | |
| KR20220153671A (ko) | 모발 성장용 제제 | |
| JPWO2018164121A1 (ja) | 局所麻酔薬含有酸性エマルション組成物 | |
| JP7198625B2 (ja) | 水性外用医薬組成物 | |
| EP0582834A1 (en) | Pharmaceutical compositions containing esters of omega-3 polyunsatured acids and their use in the topical treatment of morbid affections | |
| JP7446711B2 (ja) | 皮膚外用組成物 |